[IgE antibody determination].
Bronchial asthma is assumed to be the representative allergic disorder, and allergic reactions play an important role in its pathogenesis in about 70% of asthmatic subjects. It is essential to identity and remove relevant causative allergen(s) from therapeutic point of view to reduce symptoms and to improve quality of life, in these patients. For this purpose, skin tests, in vitro IgE antibody measurements including CAP RAST, multiple antigen simultaneous test (MAST), AlaSTAT, LUMIWARD and quidel allergy screen (QAS), as well as histamine release test (HRT) are currently employed in Japan. This review summarizes their recent progress.